Phenotypic analysis of tetramer-stained CD8 T cells from 9 HIV-seropositive subjects
| Patients . | CD27 . | CD28 . | CD38 . | CD57 . | CD62L . | HLA-DR . | CD45RO . | CD45RA . | CB9 . | Bcl-2 . |
|---|---|---|---|---|---|---|---|---|---|---|
| 136* | +++ | ± | ± | + | − | ++++ | +++ | ± | ND | ND |
| 219* | ++++ | + | ± | ± | ± | + | +++ | ± | ++ | ++ |
| 350* | ++++ | + | − | + | + | +++ | +++ | + | + | +++ |
| 606* | ++++ | + | − | ++ | ± | ++++ | ++++ | + | ++++ | +++ |
| 701* | +++ | − | − | + | ± | ND | +++ | + | +++ | ++++ |
| 705* | ++++ | ND | +++ | + | + | ++ | + | ++ | + | ++ |
| 215† | ++++ | + | + | + | − | ++ | +++ | ± | ++++ | ND |
| 307† | ++++ | − | + | ++ | ± | ± | ++++ | − | ++++ | ++++ |
| 703† | ++++ | + | ++ | − | ± | +++ | ++ | ± | ND | ND |
| Average expression | ++++ | ± | + | + | ± | ++ | +++ | + | +++ | +++ |
| Patients . | CD27 . | CD28 . | CD38 . | CD57 . | CD62L . | HLA-DR . | CD45RO . | CD45RA . | CB9 . | Bcl-2 . |
|---|---|---|---|---|---|---|---|---|---|---|
| 136* | +++ | ± | ± | + | − | ++++ | +++ | ± | ND | ND |
| 219* | ++++ | + | ± | ± | ± | + | +++ | ± | ++ | ++ |
| 350* | ++++ | + | − | + | + | +++ | +++ | + | + | +++ |
| 606* | ++++ | + | − | ++ | ± | ++++ | ++++ | + | ++++ | +++ |
| 701* | +++ | − | − | + | ± | ND | +++ | + | +++ | ++++ |
| 705* | ++++ | ND | +++ | + | + | ++ | + | ++ | + | ++ |
| 215† | ++++ | + | + | + | − | ++ | +++ | ± | ++++ | ND |
| 307† | ++++ | − | + | ++ | ± | ± | ++++ | − | ++++ | ++++ |
| 703† | ++++ | + | ++ | − | ± | +++ | ++ | ± | ND | ND |
| Average expression | ++++ | ± | + | + | ± | ++ | +++ | + | +++ | +++ |